Interview: FDA’s Woodcock on Accelerated Approval, Clinical Trial Priorities, Patent Reform

After an FDA career that has spanned more than three decades, former FDA Acting Commissioner Janet Woodcock — who now serves as principal deputy commissioner — still plays a significant role in guiding the agency.
Source: Drug Industry Daily